tiprankstipranks
Edwards Lifesciences (EW)
NYSE:EW
US Market
Want to see EW full AI Analyst Report?

Edwards Lifesciences (EW) Stock Forecast & Price Target

1,951 Followers
See the Price Targets and Ratings of:

EW Analyst Ratings

Moderate Buy
22Ratings
Moderate Buy
16 Buy
6 Hold
0 Sell
Based on 22 analysts giving stock ratings to
Edwards
Lifesciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

EW Stock 12 Month Forecast

Average Price Target

$96.74
▲(19.44% Upside)
Based on 22 Wall Street analysts offering 12 month price targets for Edwards Lifesciences in the last 3 months. The average price target is $96.74 with a high forecast of $110.00 and a low forecast of $85.00. The average price target represents a 19.44% change from the last price of $80.99.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"74":"$74","111":"$111","83.25":"$83.3","92.5":"$92.5","101.75":"$101.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":110,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$110.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":96.73684210526315,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$96.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":85,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$85.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[74,83.25,92.5,101.75,111],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,83.98,85.98153846153846,87.98307692307692,89.98461538461538,91.98615384615385,93.98769230769231,95.98923076923077,97.99076923076923,99.99230769230769,101.99384615384616,103.99538461538461,105.99692307692308,107.99846153846154,{"y":110,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,83.98,84.9612955465587,85.94259109311741,86.92388663967611,87.90518218623482,88.88647773279352,89.86777327935222,90.84906882591093,91.83036437246963,92.81165991902833,93.79295546558704,94.77425101214574,95.75554655870445,{"y":96.73684210526315,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,83.98,84.05846153846154,84.13692307692308,84.21538461538462,84.29384615384616,84.3723076923077,84.45076923076924,84.52923076923076,84.6076923076923,84.68615384615384,84.76461538461538,84.84307692307692,84.92153846153846,{"y":85,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":75.18,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.1,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.18,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.33,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.77,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.31,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.45,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.27,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.25,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.65,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.18,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.26,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.98,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$110.00Average Price Target$96.74Lowest Price Target$85.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on EW
Piper Sandler
Piper Sandler
$100
Buy
23.47%
Upside
Reiterated
05/05/26
Edwards Lifesciences (EW) Gets a Buy from Piper Sandler
Evercore ISI Analyst forecast on EW
Evercore ISI
Evercore ISI
$93
Buy
14.83%
Upside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (NASDAQ: ORIC), Fortrea Holdings Inc. (NASDAQ: FTRE) and Edwards Lifesciences (NYSE: EW)
TD Cowen
$97
Buy
19.77%
Upside
Reiterated
05/05/26
Edwards Lifesciences Maintained at Buy as Strong Q1 Results and RESILIA Durability Data Support Elevated 2026 Outlook and Unchanged $97 Price Target
Jefferies
$102
Buy
25.94%
Upside
Reiterated
04/24/26
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (NASDAQ: GILD), Regeneron (NASDAQ: REGN) and Edwards Lifesciences (NYSE: EW)
Truist Financial Analyst forecast on EW
Truist Financial
Truist Financial
$89$90
Hold
11.12%
Upside
Reiterated
04/24/26
Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (NYSE: EVMN) and Edwards Lifesciences (NYSE: EW)
Mizuho Securities Analyst forecast on EW
Mizuho Securities
Mizuho Securities
$95$100
Buy
23.47%
Upside
Reiterated
04/24/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Medpace Holdings (NASDAQ: MEDP), Siegfried Holding AG (Other OTC: SGFEF) and Edwards Lifesciences (NYSE: EW)
Robert W. Baird Analyst forecast on EW
Robert W. Baird
Robert W. Baird
$85$87
Hold
7.42%
Upside
Reiterated
04/24/26
Edwards Lifesciences price target raised to $87 from $85 at BairdEdwards Lifesciences price target raised to $87 from $85 at Baird
Barclays Analyst forecast on EW
Barclays
Barclays
$104$110
Buy
35.82%
Upside
Reiterated
04/24/26
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW), West Pharmaceutical Services (NYSE: WST) and Cochlear (Other OTC: CHEOF)
Canaccord Genuity Analyst forecast on EW
Canaccord Genuity
Canaccord Genuity
$87$85
Hold
4.95%
Upside
Reiterated
04/24/26
Edwards Lifesciences price target lowered to $85 from $87 at CanaccordEdwards Lifesciences price target lowered to $85 from $87 at Canaccord
RBC Capital
$100
Buy
23.47%
Upside
Reiterated
04/24/26
Edwards Lifesciences (EW) Gets a Buy from RBC Capital
Stifel Nicolaus Analyst forecast on EW
Stifel Nicolaus
Stifel Nicolaus
$110
Buy
35.82%
Upside
Reiterated
04/24/26
Analysts Offer Insights on Healthcare Companies: Definium Therapeutics (NASDAQ: DFTX) and Edwards Lifesciences (NYSE: EW)
William Blair Analyst forecast on EW
William Blair
William Blair
Buy
Reiterated
04/24/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
BTIG
$98$100
Buy
23.47%
Upside
Reiterated
04/24/26
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW) and Thermo Fisher (NYSE: TMO)
Bank of America Securities Analyst forecast on EW
Bank of America Securities
Bank of America Securities
$103$100
Buy
23.47%
Upside
Reiterated
04/23/26
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW) and Sanofi (Other OTC: SNYNF)
Citi
$101
Buy
24.71%
Upside
Reiterated
04/07/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (NYSE: EW), Alcon (NYSE: ALC) and Elanco Animal Health (NYSE: ELAN)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on EW
Piper Sandler
Piper Sandler
$100
Buy
23.47%
Upside
Reiterated
05/05/26
Edwards Lifesciences (EW) Gets a Buy from Piper Sandler
Evercore ISI Analyst forecast on EW
Evercore ISI
Evercore ISI
$93
Buy
14.83%
Upside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (NASDAQ: ORIC), Fortrea Holdings Inc. (NASDAQ: FTRE) and Edwards Lifesciences (NYSE: EW)
TD Cowen
$97
Buy
19.77%
Upside
Reiterated
05/05/26
Edwards Lifesciences Maintained at Buy as Strong Q1 Results and RESILIA Durability Data Support Elevated 2026 Outlook and Unchanged $97 Price Target
Jefferies
$102
Buy
25.94%
Upside
Reiterated
04/24/26
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (NASDAQ: GILD), Regeneron (NASDAQ: REGN) and Edwards Lifesciences (NYSE: EW)
Truist Financial Analyst forecast on EW
Truist Financial
Truist Financial
$89$90
Hold
11.12%
Upside
Reiterated
04/24/26
Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (NYSE: EVMN) and Edwards Lifesciences (NYSE: EW)
Mizuho Securities Analyst forecast on EW
Mizuho Securities
Mizuho Securities
$95$100
Buy
23.47%
Upside
Reiterated
04/24/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Medpace Holdings (NASDAQ: MEDP), Siegfried Holding AG (Other OTC: SGFEF) and Edwards Lifesciences (NYSE: EW)
Robert W. Baird Analyst forecast on EW
Robert W. Baird
Robert W. Baird
$85$87
Hold
7.42%
Upside
Reiterated
04/24/26
Edwards Lifesciences price target raised to $87 from $85 at BairdEdwards Lifesciences price target raised to $87 from $85 at Baird
Barclays Analyst forecast on EW
Barclays
Barclays
$104$110
Buy
35.82%
Upside
Reiterated
04/24/26
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW), West Pharmaceutical Services (NYSE: WST) and Cochlear (Other OTC: CHEOF)
Canaccord Genuity Analyst forecast on EW
Canaccord Genuity
Canaccord Genuity
$87$85
Hold
4.95%
Upside
Reiterated
04/24/26
Edwards Lifesciences price target lowered to $85 from $87 at CanaccordEdwards Lifesciences price target lowered to $85 from $87 at Canaccord
RBC Capital
$100
Buy
23.47%
Upside
Reiterated
04/24/26
Edwards Lifesciences (EW) Gets a Buy from RBC Capital
Stifel Nicolaus Analyst forecast on EW
Stifel Nicolaus
Stifel Nicolaus
$110
Buy
35.82%
Upside
Reiterated
04/24/26
Analysts Offer Insights on Healthcare Companies: Definium Therapeutics (NASDAQ: DFTX) and Edwards Lifesciences (NYSE: EW)
William Blair Analyst forecast on EW
William Blair
William Blair
Buy
Reiterated
04/24/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
BTIG
$98$100
Buy
23.47%
Upside
Reiterated
04/24/26
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW) and Thermo Fisher (NYSE: TMO)
Bank of America Securities Analyst forecast on EW
Bank of America Securities
Bank of America Securities
$103$100
Buy
23.47%
Upside
Reiterated
04/23/26
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW) and Sanofi (Other OTC: SNYNF)
Citi
$101
Buy
24.71%
Upside
Reiterated
04/07/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (NYSE: EW), Alcon (NYSE: ALC) and Elanco Animal Health (NYSE: ELAN)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Edwards Lifesciences

3 Months
xxx
Success Rate
17/27 ratings generated profit
63%
Average Return
+0.92%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 62.96% of your transactions generating a profit, with an average return of +0.92% per trade.
1 Year
Jayson BedfordRaymond James
Success Rate
17/25 ratings generated profit
68%
Average Return
+11.39%
Copying Jayson Bedford's trades and holding each position for 1 Year would result in 68.00% of your transactions generating a profit, with an average return of +11.39% per trade.
2 Years
xxx
Success Rate
15/25 ratings generated profit
60%
Average Return
+16.41%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 60.00% of your transactions generating a profit, with an average return of +16.41% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

EW Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
42
49
36
35
26
Hold
12
18
11
11
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
54
67
47
46
29
In the current month, EW has received 26 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. EW average Analyst price target in the past 3 months is 96.74.
Each month's total comprises the sum of three months' worth of ratings.

EW Financial Forecast

EW Earnings Forecast

Next quarter’s earnings estimate for EW is $0.74 with a range of $0.73 to $0.77. The previous quarter’s EPS was $0.78. EW beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year EW has Performed in-line its overall industry.
Next quarter’s earnings estimate for EW is $0.74 with a range of $0.73 to $0.77. The previous quarter’s EPS was $0.78. EW beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year EW has Performed in-line its overall industry.

EW Sales Forecast

Next quarter’s sales forecast for EW is $1.70B with a range of $1.68B to $1.72B. The previous quarter’s sales results were $1.65B. EW beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year EW has Performed in-line its overall industry.
Next quarter’s sales forecast for EW is $1.70B with a range of $1.68B to $1.72B. The previous quarter’s sales results were $1.65B. EW beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year EW has Performed in-line its overall industry.

EW Stock Forecast FAQ

What is EW’s average 12-month price target, according to analysts?
Based on analyst ratings, Edwards Lifesciences’s 12-month average price target is 96.74.
    What is EW’s upside potential, based on the analysts’ average price target?
    Edwards Lifesciences has 19.44% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is EW a Buy, Sell or Hold?
          Edwards Lifesciences has a consensus rating of Moderate Buy which is based on 16 buy ratings, 6 hold ratings and 0 sell ratings.
            What is Edwards Lifesciences’s price target?
            The average price target for Edwards Lifesciences is 96.74. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $110.00 ,the lowest forecast is $85.00. The average price target represents 19.44% Increase from the current price of $80.99.
              What do analysts say about Edwards Lifesciences?
              Edwards Lifesciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 22 Wall Streets Analysts.
                How can I buy shares of EW?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.